Free Trial

Cara Therapeutics (CARA) Short Interest Ratio & Short Volume

$0.62
-0.06 (-8.86%)
(As of 05/29/2024 ET)

Cara Therapeutics Short Interest Data

Current Short Interest
2,440,000 shares
Previous Short Interest
2,610,000 shares
Change Vs. Previous Month
-6.51%
Dollar Volume Sold Short
$1.85 million
Short Interest Ratio
4.4 Days to Cover
Last Record Date
May 15, 2024
Outstanding Shares
54,680,000 shares
Float Size
46,650,000 shares
Short Percent of Float
5.23%
Today's Trading Volume
301,997 shares
Average Trading Volume
566,156 shares
Today's Volume Vs. Average
53%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Cara Therapeutics ?

Sign up to receive the latest short interest report for Cara Therapeutics and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

CARA Short Interest Over Time

CARA Days to Cover Over Time

CARA Percentage of Float Shorted Over Time

Cara Therapeutics Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
5/15/20242,440,000 shares $1.85 million -6.5%5.2%4.4 $0.76
4/30/20242,610,000 shares $1.96 million No Change5.6%4.4 $0.75
4/15/20242,610,000 shares $1.85 million +1.2%5.6%4.1 $0.71
3/31/20242,580,000 shares $2.35 million +4.0%5.6%3.7 $0.91
3/15/20242,480,000 shares $2.18 million +3.8%5.3%3.1 $0.88
2/29/20242,390,000 shares $2.03 million +7.2%5.2%2.5 $0.85
2/15/20242,230,000 shares $1.33 million -11.2%4.8%2.5 $0.60
1/31/20242,510,000 shares $1.42 million +5.5%5.4%3.2 $0.57
1/15/20242,380,000 shares $1.36 million +3.0%5.1%3.1 $0.57
12/31/20232,310,000 shares $1.72 million +6.5%5.0%3.1 $0.74
12/15/20232,170,000 shares $2.67 million -38.9%4.7%3.2 $1.23
11/30/20233,550,000 shares $3.43 million +3.8%7.7%6.2 $0.97
11/15/20233,420,000 shares $3.83 million +15.2%7.4%5.6 $1.12
10/31/20232,970,000 shares $3.83 million +9.6%6.6%5 $1.29
10/15/20232,710,000 shares $3.85 million +9.7%6.0%4.1 $1.42
9/30/20232,470,000 shares $4.15 million +10.3%5.5%3.5 $1.68
9/15/20232,240,000 shares $5.24 million +44.5%5.0%2 $2.34
8/31/20231,550,000 shares $3.98 million -40.8%3.5%1.2 $2.57
8/15/20232,620,000 shares $7.86 million -24.5%5.8%1.9 $3.00
7/31/20233,470,000 shares $11.56 million -12.6%8.1%2.5 $3.33
7/15/20233,970,000 shares $11.35 million +6.7%9.3%2.9 $2.86
6/30/20233,720,000 shares $10.53 million -35.3%8.7%2.8 $2.83
6/15/20235,750,000 shares $18.57 million +12.5%13.5%5.9 $3.23
5/31/20235,110,000 shares $16.25 million +2.0%12.0%6.8 $3.18
5/15/20235,010,000 shares $20.79 million No Change11.7%6.8 $4.15
4/30/20235,010,000 shares $21.04 million +3.5%11.9%7.5 $4.20
4/15/20234,840,000 shares $20.47 million -9.4%11.4%7.5 $4.23
3/31/20235,340,000 shares $26.22 million +3.9%12.6%8.6 $4.91
3/15/20235,140,000 shares $29.61 million -6.4%12.2%8.7 $5.76
2/28/20235,490,000 shares $55.78 million -1.4%13.0%11 $10.16
2/15/20235,570,000 shares $57.71 million +3.9%13.3%15.2 $10.36
1/31/20235,360,000 shares $62.60 million +6.4%12.8%15.3 $11.68
1/15/20235,040,000 shares $54.68 million +1.6%12.0%14.1 $10.85
12/30/20224,960,000 shares $53.27 million -10.8%11.8%13.8 $10.74
12/15/20225,560,000 shares $62.11 million -0.4%13.2%16.4 $11.17
11/30/20225,580,000 shares $65.84 million -9.4%13.3%16.5 $11.80
11/15/20226,160,000 shares $69.79 million -1.8%14.7%18.1 $11.33
10/31/20226,270,000 shares $58.94 million -1.7%14.9%17.1 $9.40
10/15/20226,380,000 shares $64.82 million -3.6%15.2%16.4 $10.16
9/30/20226,620,000 shares $61.96 million -7.2%15.8%16.4 $9.36
Biden Nomination CANCELED? (Ad)

The Hill just published that Joe Biden has received enough delegates to…“clinch the Democratic presidential nomination and all but guaranteeing he will face off against former President Trump again in November.” Why is he all BUT guaranteed the Democratic nomination, in their words?

I believe I have the terrifying answer right here.
9/15/20227,130,000 shares $73.65 million No Change17.0%16.5 $10.33
8/31/20227,130,000 shares $73.58 million -0.7%17.0%16.4 $10.32
8/15/20227,180,000 shares $84.37 million -0.8%17.1%15.1 $11.75
7/31/20227,240,000 shares $63.28 million +3.0%16.3%12.6 $8.74
7/15/20227,030,000 shares $65.03 million +8.2%15.8%11.4 $9.25
6/30/20226,500,000 shares $59.35 million +3.5%14.6%10 $9.13
6/15/20226,280,000 shares $49.86 million +3.6%14.1%9.8 $7.94
5/31/20226,060,000 shares $50.42 million +13.3%13.6%9.1 $8.32
5/15/20225,350,000 shares $44.94 million +30.2%12.0%7.8 $8.40
4/30/20224,110,000 shares $35.84 million -2.4%9.2%6.9 $8.72
4/15/20224,210,000 shares $58.27 million +2.9%9.5%7.7 $13.84
3/31/20224,090,000 shares $49.69 million +1.0%9.2%8.2 $12.15
3/15/20224,050,000 shares $46.37 million +29.4%9.1%8.4 $11.45
2/28/20223,130,000 shares $32.46 million +25.2%7.1%6.3 $10.37
2/15/20222,500,000 shares $26.43 million +50.6%5.7%5.1 $10.57
1/31/20221,660,000 shares $19.22 million -4.6%3.8%3.2 $11.58
1/15/20221,740,000 shares $20.79 million -7.0%N/A0 $11.95
12/31/20211,870,000 shares $22.78 million -9.7%4.2%2.8 $12.18
12/15/20212,070,000 shares $25.83 million -19.8%4.7%3.1 $12.48
11/30/20212,580,000 shares $34.00 million +4.5%5.9%3.7 $13.18
11/15/20212,470,000 shares $38.63 million -14.8%5.6%2.7 $15.64
10/29/20212,900,000 shares $48.81 million +37.4%7.3%1.8 $16.83
10/15/20212,110,000 shares $27.77 million -0.5%5.3%1.4 $13.16
9/30/20212,120,000 shares $32.75 million -30.3%5.3%1.4 $15.45
9/15/20213,040,000 shares $44.90 million -21.5%7.6%2 $14.77
8/31/20213,870,000 shares $61.07 million +29.4%9.6%2.6 $15.78
8/13/20212,990,000 shares $41.41 million -2.0%7.4%4.3 $13.85
7/30/20213,050,000 shares $36.51 million No Change7.8%5.4 $11.97
7/15/20213,050,000 shares $39.47 million -3.8%7.8%3.6 $12.94
6/30/20213,170,000 shares $45.24 million -10.5%8.1%3.4 $14.27
6/15/20213,540,000 shares $50.20 million +12.4%9.0%2.8 $14.18
5/28/20213,150,000 shares $42.81 million -11.8%8.0%2.5 $13.59
5/14/20213,570,000 shares $45.98 million -7.8%9.1%2.9 $12.88
4/30/20213,870,000 shares $54.45 million +8.1%9.9%3 $14.07
4/15/20213,580,000 shares $102.10 million +30.7%9.3%3.8 $28.52
3/31/20212,740,000 shares $56.42 million -14.6%7.1%3.1 $20.59
3/15/20213,210,000 shares $61.95 million +4.6%8.3%6.3 $19.30
2/26/20213,070,000 shares $59.13 million +9.6%7.9%6.1 $19.26
2/12/20212,800,000 shares $55.75 million -4.4%7.2%5.8 $19.91
1/29/20212,930,000 shares $54.15 million -18.2%7.6%6.5 $18.48
1/15/20213,580,000 shares $64.62 million -6.8%9.2%8.2 $18.05
12/31/20203,840,000 shares $59.06 million -3.0%9.9%9.3 $15.38
12/15/20203,960,000 shares $59.00 million +2.9%10.2%9.3 $14.90
11/30/20203,850,000 shares $57.56 million +0.5%9.9%9.1 $14.95
11/15/20203,830,000 shares $59.02 million No Change10.1%9.3 $15.41
10/30/20203,830,000 shares $50.44 million -15.3%10.7%9.8 $13.17
10/15/20204,520,000 shares $60.52 million +2.5%12.6%11.6 $13.39
9/30/20204,410,000 shares $56.12 million +14.8%10.3%11.7 $12.73
9/15/20203,840,000 shares $58.56 million +2.4%9.0%10.3 $15.25
8/31/20203,750,000 shares $58.13 million +2.7%8.8%9.3 $15.50
Biden Nomination CANCELED? (Ad)

The Hill just published that Joe Biden has received enough delegates to…“clinch the Democratic presidential nomination and all but guaranteeing he will face off against former President Trump again in November.” Why is he all BUT guaranteed the Democratic nomination, in their words?

I believe I have the terrifying answer right here.
8/14/20203,650,000 shares $59.46 million -1.1%8.5%8.5 $16.29
7/31/20203,690,000 shares $60.66 million -3.2%8.7%7.6 $16.44
7/15/20203,810,000 shares $68.28 million -5.0%9.0%7.4 $17.92
6/30/20204,010,000 shares $67.29 million +12.0%9.5%7.4 $16.78
6/15/20203,580,000 shares $55.56 million -2.2%8.5%6.6 $15.52
5/29/20203,660,000 shares $58.08 million -2.1%8.6%6.7 $15.87
5/15/20203,740,000 shares $56.25 million +14.0%8.8%6.6 $15.04
4/30/20203,280,000 shares $48.61 million -6.0%7.7%6.4 $14.82
4/15/20203,490,000 shares $48.62 million -5.4%8.2%6.8 $13.93
3/31/20203,690,000 shares $58.45 million -13.2%8.7%6.9 $15.84
3/13/20204,251,500 shares $58.54 million -1.6%12.2%8.2 $13.77
2/28/20204,320,000 shares $47.78 million +0.2%12.4%7.2 $11.06
2/14/20204,310,000 shares $60.25 million -5.5%10.2%5.9 $13.98
1/31/20204,560,000 shares $72.32 million -6.0%10.7%6.2 $15.86
1/15/20204,850,000 shares $83.81 million -9.7%11.4%6.6 $17.28
12/31/20195,370,000 shares $86.19 million -0.7%12.7%7.9 $16.05

CARA Short Interest - Frequently Asked Questions

What is Cara Therapeutics' current short interest?

Short interest is the volume of Cara Therapeutics shares that have been sold short but have not yet been closed out or covered. As of May 15th, traders have sold 2,440,000 shares of CARA short. 5.23% of Cara Therapeutics' shares are currently sold short. Learn More on Cara Therapeutics' current short interest.

What is a good short interest ratio for Cara Therapeutics?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CARA shares currently have a short interest ratio of 4.0. Learn More on Cara Therapeutics's short interest ratio.

Which institutional investors are shorting Cara Therapeutics?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Cara Therapeutics: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

What is a good short interest percentage for Cara Therapeutics?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 5.23% of Cara Therapeutics' floating shares are currently sold short.

Is Cara Therapeutics' short interest increasing or decreasing?

Cara Therapeutics saw a decrease in short interest during the month of May. As of May 15th, there was short interest totaling 2,440,000 shares, a decrease of 6.5% from the previous total of 2,610,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Cara Therapeutics' float size?

Cara Therapeutics currently has issued a total of 54,680,000 shares. Some of Cara Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Cara Therapeutics currently has a public float of 46,650,000 shares.

How does Cara Therapeutics' short interest compare to its competitors?

5.23% of Cara Therapeutics' shares are currently sold short. Here is how the short interest of companies compare to Cara Therapeutics: Sagimet Biosciences Inc. (10.29%), RAPT Therapeutics, Inc. (8.91%), InterCure Ltd. (0.26%), Rezolute, Inc. (0.77%), I-Mab (1.46%), Gossamer Bio, Inc. (5.56%), Seres Therapeutics, Inc. (15.01%), CytomX Therapeutics, Inc. (11.23%), Syros Pharmaceuticals, Inc. (7.64%), Repare Therapeutics Inc. (1.82%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.81 billion), Charter Communications, Inc. ($3.30 billion), Occidental Petroleum Co. ($3.10 billion), General Motors ($2.84 billion), Moderna, Inc. ($2.77 billion), AppLovin Co. ($2.22 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.16 billion), Tractor Supply ($2.12 billion), and Williams-Sonoma, Inc. ($2.12 billion). View all of the most shorted stocks.

What does it mean to sell short Cara Therapeutics stock?

Short selling CARA is an investing strategy that aims to generate trading profit from Cara Therapeutics as its price is falling. CARA shares are trading down $0.06 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Cara Therapeutics?

A short squeeze for Cara Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of CARA, which in turn drives the price of the stock up even further.

How often is Cara Therapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CARA, twice per month. The most recent reporting period available is May, 15 2024.



More Short Interest Resources from MarketBeat

This page (NASDAQ:CARA) was last updated on 5/30/2024 by MarketBeat.com Staff

From Our Partners